• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PACS Group Inc.

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    SC 13G 1 pacs-jasonhulsemurray13g11.htm SC 13G Document

    Securities and Exchange Commission
    Washington, D.C. 20549
    Schedule 13G
    (Rule 13d-102)
    Information to be Included in Statements Filed Pursuant
    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed
    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. )*

    PACS Group, Inc.
    (Name of Issuer)

    Common Stock
    (Title of Class of Securities)
    69380Q107
    (CUSIP Number)
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [ ]    Rule 13d-1(b)
    [ ]    Rule 13d-1(c)
    [X]    Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    CUSIP No. 69380Q107
    Schedule 13G
    Page 1 of 4

        1
    Names of Reporting Persons

    Jason Hulse Murray
        2
    Check the Appropriate Box if a Member of a Group

    (a) [X] (b) [ ]
        3
    SEC Use Only

        4
    Citizenship or Place of Organization

    United States
    Number of Shares Beneficially Owned by Each Reporting Person With
    5
    Sole Voting Power
    54,626,199
    6
    Shared Voting Power
    0
    7
    Sole Dispositive Power
    54,626,199
    8
    Shared Dispositive Power

    0
        9
    Aggregate Amount Beneficially Owned by Each Reporting Person

        54,626,199
        10
    Check if the Aggregate Amount in Row (9) Excludes Certain Shares

        
    Not Applicable
        11
    Percent of Class Represented by Amount in Row 9

        
    35.2%
        12
    Type of Reporting Person

        
    IN



    CUSIP No. 69380Q107
    Schedule 13G
    Page 2 of 4

    ITEM 1.(a)    Name of Issuer:
    PACS Group, Inc. (the “Issuer”).
    (b)Address of Issuer’s Principal Executive Offices:

    262 N. University Ave., Farmington, Utah 84025.
    ITEM 2.(a)    Name of Person Filing:
    This statement is filed on behalf of Jason Hulse Murray (the “Reporting Person”).
    (b)Address or Principal Business Office:
    The business address of the Reporting Person is c/o PACS Group, Inc., 262 N. University Ave., Farmington, Utah 84025.
    (c)Citizenship:

    The Reporting Person is a citizen of the United States of America.

    (d)Title of Class of Securities:

    Common stock, par value $0.001 per share (“Common Stock”).
    (e)CUSIP Number:

    69380Q107
    ITEM 3.
    Not applicable.
    ITEM 4.Ownership.

        The ownership information below represents beneficial ownership of shares of Common Stock as of September 30, 2024, based upon 155,177,511 shares of Common Stock outstanding as of September 9, 2024.
    (a) Amount beneficially owned:
    The Reporting Person is the record holder of 45,126,199 shares of Common Stock and the beneficial owner of 9,500,000 shares of Common Stock held in Cougar 1, LLC, a limited liability company of which he is the sole owner.


    CUSIP No. 69380Q107
    Schedule 13G
    Page 3 of 4

    (b) Percent of class: 35.2%
    (c) Number of shares as to which the person has:
    (i)Sole power to vote or to direct the vote: 54,626,199
    (ii)Shared power to vote or direct the vote: 0
    (iii)Sole power to dispose or to direct the disposition of: 54,626,199
    (iv)Shared power to dispose or to direct the disposition of: 0
    ITEM 5.Ownership of Five Percent or Less of a Class.
        Not applicable.
    ITEM 6.Ownership of More than Five Percent on Behalf of Another Person.
    The Reporting Person and Mark Hancock are parties to a Stockholders Agreement (the “Stockholders Agreement”), which contains, among other things, certain provisions relating to transfer of, and coordination of the voting of, securities of the Issuer by the parties thereto.
    By virtue of the Stockholders Agreement and the obligations and rights thereunder, the Reporting Person acknowledges and agrees that he is acting as a “group” with Mr. Hancock within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Reporting Person expressly disclaims beneficial ownership over any shares of Common Stock that he may be deemed to beneficially own solely by reason of the Stockholders Agreement. Mr. Hancock is separately filing a Schedule 13G reporting his beneficial ownership of the Common Stock.
    ITEM 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
    Not applicable.
    ITEM 8.Identification and Classification of Members of the Group.

    Not applicable.
    ITEM 9.Notice of Dissolution of Group.
    Not applicable.
    ITEM 10. Certification.
    Not applicable.


    CUSIP No. 69380Q107
    Schedule 13G
    Page 4 of 4

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:    November 14, 2024

    Jason Hulse Murray

    /s/ Jason Hulse Murray            


    Get the next $PACS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group Announces Business Updates

    Entered into Amendment and Waiver to Existing Credit Agreement Acquires Operations and Real Estate of 160-Bed Skilled Nursing Facility in Nevada PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced several business updates that build on the Company's momentum and strong year-to-date operational and financial performance. "The amendment and waiver to our credit agreement and the latest addition to our growing portfolio demonstrate how our team continues to execute on our strategy and position our business for continued growth," said Jason Murray, PACS's Chief Execu

    12/1/25 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    UBS initiated coverage on PACS Group with a new price target

    UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

    10/9/24 7:56:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Legal Officer & Sec. Mitchell John Todd sold $4,768,379 worth of shares (159,556 units at $29.89), decreasing direct ownership by 17% to 755,836 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:44:06 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:32:30 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    SEC Filings

    View All

    PACS Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/1/25 4:02:18 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form DEF 14A filed by PACS Group Inc.

    DEF 14A - PACS Group, Inc. (0002001184) (Filer)

    11/25/25 4:03:34 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form 144 filed by PACS Group Inc.

    144 - PACS Group, Inc. (0002001184) (Subject)

    11/24/25 5:29:28 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group Announces Business Updates

    Entered into Amendment and Waiver to Existing Credit Agreement Acquires Operations and Real Estate of 160-Bed Skilled Nursing Facility in Nevada PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced several business updates that build on the Company's momentum and strong year-to-date operational and financial performance. "The amendment and waiver to our credit agreement and the latest addition to our growing portfolio demonstrate how our team continues to execute on our strategy and position our business for continued growth," said Jason Murray, PACS's Chief Execu

    12/1/25 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care